<DOC>
	<DOCNO>NCT01597570</DOCNO>
	<brief_summary>It purpose verify superiority Fastseal® Bioabsorbable Vascular Access Closure System effectiveness safety confirmation hemostasis ( TTH ; Time hemstasis ) ambulation ( TTA ; Time ambulation ) puncture site common femoral artery ( CFA ) procedures Fastseal® Biosorbable Vascular Access Closure System Perclose® ProGlide Suture-Mediated Closure System 1 month observation .</brief_summary>
	<brief_title>Effectiveness Safety Confirmation Between FASTSEAL® Bioabsorbable VCD Perclose® ProGlide SMC System</brief_title>
	<detailed_description>Prospective , Single blind , randomize Comparative study use Fastseal® Bioabsorbable Vascular Access Closure System investigational device Perclose® ProGlide Suture-Mediated Closure System comparator . After go confirmation inclusion/exclusion criterion sign subject , procedure either two device . The subject follow designate physician 's instruction accurately clinical trial period.There 6 time evaluation Including screening .</detailed_description>
	<criteria>Between 20 year old 85 year old , randomized Patient submit write informed consent trial The subject schedule angiography intervention common femoral artery ( CFA ) . The subject must use 6Fr sheath Terumo 's RadiFocus Introducer II . In case subject functure site leg . The patient closing device insertion manual compression target femoral artery within 30 day Patients severe bleed disorder ( Severe bleed history , blood coagulation disorder , thrombocytopenia ( 100,000 platelet count ) , hemophilia , anemia ( Hgb &lt; 10g/dL , Hct &lt; 30 % ) , Thrombasthenia , relate bleed disorder Hypertension patient BP ≥180/110mmHg In case thrombolysis ( ex : streptokinase , urokinase , tPA ) within 24hr If hematoma , arteriovenous fistula ( AVF ) , false aneurysm exist access site femoral artery Severe obesity BMI &gt; 40kg/m2 In case prior stent placement artificial vessel insertion common femoral artery ( CFA ) Under 5mm Common femoral artery ( CFA ) diameter</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>